Ozempic and Wegovy have been hailed as wonder drugs when it comes to weight loss
"Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal PubMed A glucagon-like peptide-1 receptor agonist (GLP-1RA) has recently been established as a pharmacological option for the treatment of type 2 diabetes
Neil Floch, an internationally known and respected bariatric surgeon, has expressed his professional perspective on weight loss drugs across digital platforms, conveying that while these drugs may help some individuals, they are not a sufficient and reliable replacement for bariatric surgery
10.1152/ajpendo.00030.2002 162
While albiglutide demonstrated good glycemic efficacy and tolerability, adverse effects included upper respiratory tract infections, diarrhea, nausea, and injection site reactions